Rupee rises 8 paise to 74.79 against U.S. dollar in early trade
The Hindu
The rupee on October 21 ended on a flat note at 74.87 against the U.S. dollar
The Indian rupee appreciated 8 paise to 74.79 against the U.S. dollar in opening trade on October 22, tracking a positive trend in domestic equities.
At the interbank foreign exchange, the rupee opened at 74.82 against the dollar, then edged higher to 74.79, registering a rise of 8 paise over its previous close.
The rupee on October 21 ended on a flat note at 74.87 against the U.S. dollar.
MTNL shares surge 18% after earning ₹2,134.61 crore from land monetisation, government informs Parliament. Market benchmarks rise.
February 2025 saw a 2% increase in passenger vehicle sales in India, with upcoming festivals expected to boost demand.
Fitch Ratings revises outlook on Adani Group entities to Stable, affirms 'BBB-' rating, and takes rating action on other bonds.
Equity market benchmarks Sensex and Nifty rise on strong domestic data and global trends, led by ICICI Bank and Reliance: Follow The Hindu’s updates on the Sensex and Nifty
Scopely will pay $3.5 billion to acquire Niantic’s game unit, including the studio behind Pokemon Go.
Follow The Hindu’s updates on the rupee : Mumbai forex analysts report on rupee's gains against the dollar amid global tariff tensions and economic data.
The U.S. Federal Trade Commission is moving ahead with an antitrust probe of Microsoft, Bloomberg News reported.
Intel hires semiconductor industry veteran Lip-Bu Tan as CEO to revive struggling company amid leadership changes and financial challenges.
Nandan Nilekani predicts India as top IPO market by 2035 with 1 million startups and $8 trillion economy potential.
BNW Developments partners with Taj to bring luxury living to UAE's Al Marjan Island, Ras Al Khaimah.
Equity indices Sensex and Nifty close lower amid global economic concerns, with IT and telecom stocks leading the decline.
Rupee closes at 87.19 against US dollar amid tariff uncertainties, crude oil prices, and global market volatility.
NCLAT rejects IRDA pleas against Shriram Group insurance arm mergers, citing no statutory bar under Insurance Act.